Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
- 1 March 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (9) , 571-576
- https://doi.org/10.1016/0002-9149(89)90901-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Pimobendan Increases Survival of Cardiomyopathic HamstersJournal of Cardiovascular Pharmacology, 1989
- Effects of Pimobendan (UD-CG 115) on the Contractile Function of the Normal and “Postischemic” Canine MyocardiumJournal of Cardiovascular Pharmacology, 1988
- Systemic haemodynamic actions of pimobendan (UD‐CG 115 BS) and its O‐demethylmetabolite UD‐CG 212 Cl in the conscious pigBritish Journal of Pharmacology, 1987
- Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin CBiochemical and Biophysical Research Communications, 1987
- Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigsEuropean Journal of Pharmacology, 1987
- Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic propertiesEuropean Journal of Pharmacology, 1986
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Inotropic drugs and their mechanisms of actionJournal of the American College of Cardiology, 1984
- Positive Inotropic AgentsAnnual Review of Pharmacology and Toxicology, 1984
- UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984